News

Carbon-encapsulated magnetite nanodonut suggested for synergistic cancer therapy

25 Aug 2023
Carbon-encapsulated magnetite nanodonut suggested for synergistic cancer therapy

Recently, a research team led by Prof. WANG Hui from Hefei Institutes of Physical Science (HFIPS), Chinese Academy of Sciences (CAS), in collaboration with researchers from the University of Washington, constructed a photoresponsive carbon encapsulated magneto nanodonut (CEMNDs) nanoenzyme with dual catalytic activity for photothermally enhanced chemodynamic cancer synergistic therapy, using the Steady-State High Magnetic Field Experimental Facility (SHMFF).

The relevant results were published in Advanced Healthcare Materials.

Iron-based nanoenzyme-mediated chemodynamic therapy (CDT) has attracted great attention in tumour catalytic therapy in recent years.

However, tumour cells' limited uptake of iron-based nanoenzyme and weak iron ion release make cancer treatment challenging.

It is effective in creating the quasi-two-dimensional structure of the iron-based nano-enzyme to boost tumour cell uptake.

Iron-based nanoenzyme's quasi-two-dimensional structure leads to increased specific surface area, enabling faster iron ion release and improved Fenton reaction hydroxyl radical (·OH) formation, optimising tumour therapy.

In this study, researchers introduced light-responsive CEMNDs that exhibited dual-catalytic activities for CDT.

"CEMNDs can accumulate within tumour sites and penetrate tumour cells, where they act as peroxidase enzymes to convert H2O2 into ·OH" said MENG Xiangfu, first author of the paper, "this catalytic process induces targeted tumour cell death."

The carbon layer on CEMNDs constructed by the solvothermal method was able to improve the stability and biocompatibility of the nanoenzyme.

The two-dimensional construction of CEMNDs improved the uptake rate of CEMNDS in tumour cells, accelerated the release of iron ions and Fenton reaction in the tumour microenvironment, and realised the therapeutic ability of CDT.

The glutathione oxidase activity of CEMNDs promoted the oxidation of glutathione, protected the ·OH formed by Fenton reaction, and enhanced the therapeutic effect of CDT.

In addition, the optical absorption of CEMNDs in the second near-infrared window (NIR-II) region was able to effectively convert light energy into heat energy, further realising photothermally enhanced cancer chemodynamic therapy.

The findings of this study hold promise for advancing cancer treatment modalities, according to the team.

Source: Hefei Institutes of Physical Science, Chinese Academy of Sciences